Clinical Trial Update: Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II trial evaluating TVI-Brain-1 for safety and efficacy in recurrent high-grade gliomas, including glioblastoma multiforme, has completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme
• Glioma
• High-grade Astrocytoma

Drugs mentioned

• TVI-Brain-1

Snippet

Sponsor: TVAX Biomedical | Conditions: Glioma, High Grade Astrocytoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-06-01